Table 1 Summary of patient characteristics and outcomes
a) Preoperative characteristics | b) Primary outcome measures | ||
Number of patients in total | 100 | Peri-operative MACE (%) | 0 |
Age | 62 ± 11 | Survival to discharge (%) | 100 |
Male | 95 | 30 Day MACE (%) | 0 |
BMI Kg/m2 | 27.0 ± 3.3 | Three year MACE (%) | 9 |
Diabetes (%) | 17 | Three year Incidence of Death (%) | 3 |
Mean creatinine | 100 ± 22 | Three year Incidence of MI (%) | 2 |
Carotid disease (%) | 10 | Three year Incidence of Stroke (%) | 1 |
Previous MI (%) | 18 | Three year Incidence of TVR (%) | 3 |
Poor LV (%) | 1 | Five year incidence of death (%) | 4 |
Previous PCI (%) | 13 | ||
Hybrid strategy (%) | 19 | c) Secondary outcome measures | |
Redo (%) | 1 | Conversion rate to MIDCAB (%) | 3 |
EUROScore | 1.73 ± 1.93 | Re-operation for bleeding (%) | 0 |
NYHA (III&IV) (%) | 18 | Atrial fibrillation (%) | 2 |
CCS (III&IV) (%) | 18 | Respiratory complications (%) | 4 |
Lesion charachteristic | Median length of stay (days) | 4 ± 1 | |
Type A (%) | 10 | ||
Type B (%) | 55 | ||
Type C (%) | 35 | ||